Professional product catalogue

Oncology & haematology medicines

Oncology and haematology medicines bring together related but distinct fields: antineoplastic agents, haemostasis or anaemia medicines, and immunosuppressants. Their targets range from cell multiplication to immune pathways and selected blood functions. A cytotoxic substance, coagulation factor and iron preparation do not have the same role. This category explains those families and their formulation diversity without treating every blood disorder medicine as an anticancer agent. Biological purpose and complete pharmaceutical identity provide a more precise context than broad anatomical or disease terminology alone.

Antineoplastic medicines

Antineoplastic medicines address processes involved in cancer through very different mechanisms. Cytotoxic chemotherapy, targeted therapies and selected immunotherapies form part of this category's vocabulary. Small molecule and monoclonal antibody do not describe the same substance type. Oral and injectable forms, biological targets and complete composition explain the families without attributing a common action against every cancer to each medicine or assuming an individual outcome. A broad anticancer description provides a setting while leaving the documented role of each medicinal product specific.

368 classified products

Haematological medicines

Haematological treatments in this category concern haemostasis and medicines for anaemia in particular. These functions differ: contributing to coagulation or limiting bleeding is not the same as affecting red blood cell production. Coagulation factors, antifibrinolytics, iron and haematopoietic vitamins belong to different families. Their oral or injectable presentations help explain the medicines without confusing them with anticoagulants or antineoplastic agents used for blood cancers. A shared relationship with blood does not establish a common pharmacological target, indication or pharmaceutical identity for every product.

192 classified products

Immunosuppressants

Immunosuppressants modulate or reduce selected activities of the immune system. Documented fields include transplantation and various inflammatory or autoimmune conditions, depending on the substance. Enzyme inhibitors, agents targeting cells or mediators, and other families do not share one mechanism. This category explains targets and pharmaceutical forms, distinguishing immunosuppression from other immunological approaches. It also avoids treating every biological medicine as having the same therapeutic role, since molecular type, target, indication and formulation provide different information about the identity and purpose of a medicinal product.

335 classified products